EAN News

Renin–angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

Baricitinib plus Remdesivir for Hospitalized Adults with COVID-19

Efficacy of Tocilizumab in Patients Hospitalized with COVID-19

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with COVID-19

A Neutralizing Monoclonal Antibody for Hospitalized Patients with COVID-19

Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine

Happy New Year 2021 from the EAN, the Home of Neurology

For January 2021, we have selected: Matschke et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol 2020; 19:919-929. doi: 10.1016/S1474-4422(20)30308-2.

As a Christmas Special to EAN’s RRFS members, we hosted a series of three Master Classes in the course of December 2020 for free.

Executive Page: Welcome to new year by Editor-in-Chief

For January 2021, we have selected: M. Obermann et al. Safety and efficacy of prednisone versus placebo in short-term prevention of episodic cluster headache: a multicentre, double-blind, randomised controlled trial. Lancet Neurol 2020, November 24, 2020. https://doi.org/10.1016/S1474-4422(20)30363-X.

Prof. Dafin Muresanu, Chair of the EAN Communication Committee interviews Prof. Marco Medina, President of the Pan American Federation of Neurological Societies (PAFNS)

Congress Registration is open

Abstract submission for EAN Congress 2021 is now open!